Structures by: Delarge J.
Total: 24
8-Chloro-6-(3-dimethylaminopropylamino)-11H-pyrido[2,3-b][1,4]benzodiazepine
C17H20ClN5
Acta Crystallographica Section E (2002) 58, 1 o69-o71
a=9.0010(10)Å b=20.421(3)Å c=9.9350(10)Å
α=90.00° β=109.545(6)° γ=90.00°
3-(Isopropylamino)-4-methyl-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide
C10H14N4O2S
Acta Crystallographica Section C (1996) 52, 7 1741-1743
a=6.2084(7)Å b=13.0294(14)Å c=15.0456(11)Å
α=90.00° β=95.709(6)° γ=90.00°
Nimesulide
C13H12N2O5S
Acta Crystallographica Section C (1995) 51, 3 507-509
a=33.657(3)Å b=5.1305(3)Å c=16.0816(10)Å
α=90.00° β=92.368(8)° γ=90.00°
N-Cyano-N'-Isopropyl-N"-((4-(3'-Methylphenylamino)Pyrid-3-yl)Sulfonyl) Guanidine
C17H20N6O2S
Acta Crystallographica Section C (1995) 51, 3 505-507
a=11.7356(10)Å b=13.5707(14)Å c=12.4426(11)Å
α=90.00° β=110.975(8)° γ=90.00°
C17H19N5,1.5(H2O1)
C17H19N5,1.5(H2O1)
Acta Crystallographica Section C (1992) 48, 7 1322-1324
a=11.268(3)Å b=12.815(3)Å c=13.720(4)Å
α=107.370(10)° β=98.15(2)° γ=110.420(10)°
3-methyl-4H-pyrido[3,2-e][1,2,4]thiadiazine 1,1-dioxide
C7H7N3O2S
Acta Crystallographica Section C (1995) 51, 5 944-946
a=20.709(3)Å b=7.7770(14)Å c=17.276(3)Å
α=90.00° β=143.279(5)° γ=90.00°
(R)-1-Phenylethylaminium (S)-2-(6-methoxy-2-naphthyl)propionate
C8H12N1,C14H13O31
Acta Crystallographica Section C (1996) 52, 2 393-395
a=11.6395(9)Å b=5.9814(6)Å c=13.6907(9)Å
α=90.00° β=94.462(14)° γ=90.00°
8-Chloro-5-(4-methylpiperazin-1-yl)-11H-pyrido[2,3-b][1,5]benzodiazepine
C17H18Cl1N5
Acta Crystallographica Section C (1996) 52, 2 391-393
a=11.9739(12)Å b=10.2088(11)Å c=14.662(2)Å
α=90.00° β=113.836(7)° γ=90.00°
7-Chloro-(S)-3-[1-(cyclohexyl)ethylamino]-4H-1,2,4-benzothiadiazine 1,1-dioxide
C15H20ClN3O2S
Acta Crystallographica Section C (1999) 55, 11 1945-1947
a=11.2968(4)Å b=11.8091(7)Å c=12.8835(10)Å
α=90.00° β=90.00° γ=90.00°
7-Chloro-(R)-3-[1-(cyclohexyl)ethylamino]-4H-1,2,4-benzothiadiazine 1,1-dioxide
C15H20ClN3O2S
Acta Crystallographica Section C (1999) 55, 11 1945-1947
a=11.2963(8)Å b=11.8026(11)Å c=12.8831(11)Å
α=90.00° β=90.00° γ=90.00°
3-methyl-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-dioxide
C7H7N3O2S
Acta Crystallographica Section C (1995) 51, 10 2064-2066
a=12.2439(12)Å b=10.6348(9)Å c=14.0329(13)Å
α=90.00° β=117.964(6)° γ=90.00°
3-Benzamido-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-Dioxide
C13H10N4O3S
Acta Crystallographica Section C (1995) 51, 9 1903-1905
a=9.5563(3)Å b=13.8791(8)Å c=10.9290(8)Å
α=90.00° β=111.648(2)° γ=90.00°
3-methyl-6-(4-methylpiperazin-1-yl)-11H-pyrido[2,3-b][1,4]benzodiazepine
C18H21N5
Acta Crystallographica Section C (1995) 51, 9 1889-1891
a=9.3352(6)Å b=19.2342(10)Å c=9.3903(7)Å
α=90.00° β=93.039(6)° γ=90.00°
C18H18ClN3S
C18H18ClN3S
Acta Crystallographica Section C (1992) 48, 10 1851-1853
a=9.521(3)Å b=13.007(4)Å c=14.116(6)Å
α=90° β=100.770(10)° γ=90°
3-Methyl-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-Dioxide Monohydrate
C7H7N3O2S,H2O
Acta Crystallographica Section C (1995) 51, 5 946-948
a=9.3055(6)Å b=8.4118(6)Å c=12.3965(7)Å
α=90.00° β=98.731(7)° γ=90.00°
11-(4-methylpiperazin-1-yl)-5H-pyrido[4,3-b][1,5]benzodiazepine
C17H19N5
Acta Crystallographica Section C (1995) 51, 7 1379-1381
a=9.8098(5)Å b=16.5788(10)Å c=19.1759(8)Å
α=90.00° β=90.00° γ=90.00°
4-ethyl-2,3-dihydro-4H-pyrido[3,2-e]-1,2,4-thiadiazine 1,1-dioxide
C8H11N3O2S
Acta Crystallographica Section C (1999) 55, 3 461-464
a=7.7385(12)Å b=12.199(3)Å c=20.667(2)Å
α=90.00° β=99.735(18)° γ=90.00°
4-ethyl-2,3-dihydro-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide
C8H11N3O2S
Acta Crystallographica Section C (1999) 55, 3 461-464
a=8.1628(4)Å b=11.6259(8)Å c=10.2405(11)Å
α=90.00° β=97.841(7)° γ=90.00°
3-amino-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide monohydrate
C6H6N4O2S,H2O
Acta Crystallographica Section C (1995) 51, 7 1385-1388
a=7.487(2)Å b=15.470(7)Å c=8.131(7)Å
α=90.00° β=109.55(3)° γ=90.00°
3-tert butyl-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide
C10H13N3O2S
Acta Crystallographica Section C (1995) 51, 7 1385-1388
a=9.802(9)Å b=11.682(9)Å c=10.384(16)Å
α=90.00° β=108.00(10)° γ=90.00°
2,4,7-Trimethyl-2,3-dihydro-4H-pyrido[4,3-e]-1,2,4-thiadiazinium 1,1-Dioxide Iodide
C9H14N3O2S1,I1
Acta Crystallographica Section C (1995) 51, 11 2412-2414
a=7.9184(10)Å b=8.9446(14)Å c=10.861(2)Å
α=109.410(9)° β=107.918(6)° γ=90.336(6)°
7-Methyl-3-methylsulfanyl-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-Dioxide Inner Salt
C8H9N3O2S2
Acta Crystallographica Section C (1995) 51, 11 2416-2417
a=7.3767(7)Å b=8.1696(7)Å c=8.5483(7)Å
α=82.557(9)° β=83.195(7)° γ=84.162(5)°
3,7-Dimethyl-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxide inner salt
C8H9N3O2S
Acta Crystallographica Section C (1995) 51, 11 2414-2416
a=12.641(2)Å b=5.5304(10)Å c=13.615(3)Å
α=90.00° β=105.847(15)° γ=90.00°
Terbogrel
C23H27N5O2
Acta Crystallographica Section C (2000) 56, 10 1265-1266
a=14.9340(10)Å b=10.1150(10)Å c=15.7400(10)Å
α=90.00° β=113.049(5)° γ=90.00°